Kurser indlæses...
Prognose
Vi har ingen analytikerdata for denne virksomhed.
Nyheder Til nyhedsfeedet
Cyber attack on Craneware sends shares down about 9.6%
Craneware reported a cyber incident in which unauthorized parties compromised parts of its data environment and stole extensive data, including employee, customer and partner information. The company says much of the stolen material is non-critical or already publicly available, has activated its emergency plan and engaged external cyber security and forensic specialists. According to the company, the attack has been contained, there have been no impacts to customer service or operations, and US and UK regulators have been informed. The announcement hit an already weak market mood after a profit warning over delayed revenue recognition in the 340B business and pushed the shares to a multi-month low of 1,088 pence, far below the 52-week high of 2,620 pence. » Mere på de.investing.com
Craneware supervisory board chairman Will Whitehorn acquires 640 shares
Will Whitehorn bought 640 ordinary shares of Craneware at 1,173 pence each via the London Stock Exchange and now holds 7,140 shares. His holding represents 0.021% of the issued share capital (excluding treasury shares). Craneware provides solutions for financial management in healthcare. » Mere på de.investing.com
Craneware warns of earnings decline for fiscal 2026 – shares plunge
Craneware issued an unscheduled trading update and expects revenue of $205–208m and adjusted EBITDA of $65–67m for the fiscal year ending 30 June 2026, both broadly in line with the prior year. The stock fell intraday by around 21.5% to 1,148p after the company cited delays in the timing of qualified 340B activities and the deferral of significant enterprise customer contracts to 2027 as the main reasons. Craneware attributes the delays to manufacturers’ restrictions on 340B drugs, but continues to emphasize strong customer retention, intact long‑term growth prospects and a strategic expansion into technology‑enabled operational transformation. » Mere på de.investing.com
Historisk udbytte Udbytte
Alle nøgletal for udbytte Alle nøgletalVirksomhedstal
| (EUR) | juni 2026 | YoY |
|---|---|---|
| Omsætning | 86,1 mio. | - |
| Bruttofortjeneste | 56,57 mio. | - |
| Nettoresultat | 8,32 mio. | - |
| EBITDA | 26,33 mio. | - |
Fundamentale data
| Nøgletal | Værdi |
|---|---|
Markedsværdi | 444,2 mio. € |
Antal aktier | 34,24 mio. |
Højeste/laveste i 52 uger | 29,27 € - 11,80 € |
Udbytteafkast | 2,95 % |
Udbytte TTM | 0,38 € |
Beta | -0,17 |
P/E (PE Ratio) | 25,87 |
PEG (PEG Ratio) | 0,26 |
K/I (PB Ratio) | 1,53 |
P/S (PS Ratio) | 2,43 |
Virksomhedsprofil
Craneware plc og dets datterselskaber udvikler, licenserer og understøtter computersoftware til sundhedssektoren i USA. Virksomheden leverer løsninger såsom Chargemaster Toolkit, en automatiseret software-as-a-service (SaaS) løsning til chargemaster-styring, der sikrer optimal, lovlig refusion for udbydere; Trisus Supply, en løsning, der anvender data til at identificere datahuller mellem systemerne; Physician Revenue Toolkit, en SaaS-løsning til styring af KPI'er, takster, koder, RVU'er, honorarskemaer og relaterede oplysninger for lægegrupper; Reference Plus, en SaaS-løsning til analyse af chargemaster; Pharmacy ChargeLink, en løsning til at forbedre registrering af takster, prissætning og omkostningsstyring; integration til chargemaster-styring, en software, der automatisk uploader ændringer i chargemaster til patientfaktureringssystemet for korrekt fakturering; Trisus Pricing Analyzer, en SaaS-løsning, der forenkler prismodelleringsprocessen; samt Online Reference Toolkit og forsyningsassistentløsninger. Virksomheden tilbyder desuden InSight Medical Necessity, en SaaS-løsning, der leverer validering af medicinsk nødvendighed for betalere i USA og oprettelse af meddelelser om forudgående information til patienter; Trisus Claims Informatics, en software, der automatiserer gennemgang af krav og kodning; og InSight Audit, en webbaseret revisionsstyringsapplikation til sundhedsorganisationer til håndtering af offentlige og kommercielle revisioner. Derudover leverer virksomheden Trisus Healthcare Intelligence, en platform til omkostningsanalyse og ressourceeffektivitet; trisus pricing transparency; InSight Denials til analyse, sporing, trendanalyse og rapportering af afslagsdata; og appeltjenester. Endvidere tilbyder den kundesuccessstyring og konsulentydelser; professionelle ydelser; samt salgs- og marketingydelser samt produkt- og softwareudviklingsydelser. Craneware plc blev stiftet i 1999 og har hovedkvarter i Edinburgh, Storbritannien.
| Navn | CRANEWARE PLC |
| CEO | Keith Neilson |
| Hjemsted | Edinburgh,
sc Storbritannien |
| Websted | |
| Børsnotering | 13.09.2007 |
| Medarbejdere | 765 |
Tickersymboler
| Børs | Symbol |
|---|---|
London Stock Exchange | CRW.L |
Pnk | CRWRF |
Frankfurt | 3X6.F |
Düsseldorf | 3X6.DU |
London | CRW.L |
München | 3X6.MU |